Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Clin Exp Immunol ; 175(2): 167-71, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24016298

ABSTRACT

Some type 1 diabetes (T1D) patients have been reported to exhibit T cell reactivity to wheat gluten. We tested the hypothesis that this T cell reactivity could be abolished by using prolyl-endopeptidase (PEP), an enzyme that cleaves peptide bonds after proline. Peripheral blood mononuclear cells (PBMCs) were isolated from T1D patients and healthy controls. PBMCs were stimulated with a peptic-tryptic digest of wheat gluten; a peptic-tryptic-PEP digest of wheat gluten; and a 13 amino acid peptide from wheat gluten. Fluorescent-labelled antibodies to CD3, CD4 and CD8 cell marker proteins were utilized to determine proliferative responses of CD3, CD4 and CD8 T cells. There were no significant differences in proliferative responses of CD3 or CD4 T cells to the wheat gluten antigens. A significantly higher proportion of CD8(+) T cells from T1D patients proliferated in the presence of the 13 amino acid peptide than when challenged with the peptic-tryptic or the peptic-tryptic-PEP digests of wheat gluten. PEP treatment had no significant effect on CD8 T cell reactivity to the peptic-trytic digest of wheat gluten. Our results suggest that wheat gluten-derived peptides, containing ≤ 13 amino acids, may evoke T cell responses in T1D patients.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Diabetes Mellitus, Type 1/immunology , Gliadin/immunology , Glutens/immunology , Peptides/immunology , Adolescent , Adult , Aged , CD3 Complex/immunology , CD4 Antigens/immunology , CD8 Antigens/immunology , Cell Proliferation , Child , Child, Preschool , Endopeptidases/metabolism , Female , Fluorescent Antibody Technique , Glutens/metabolism , Humans , Leukocytes, Mononuclear , Male , Middle Aged , Peptides/metabolism , Young Adult
2.
Mucosal Immunol ; 4(3): 304-13, 2011 May.
Article in English | MEDLINE | ID: mdl-21068720

ABSTRACT

Peroxisome proliferator-activated receptor-γ (PPAR-γ) is widely expressed in macrophages and has been identified as a putative target for the development of novel therapies against inflammatory bowel disease (IBD). Computational simulations identified macrophages as key targets for therapeutic interventions against IBD. This study aimed to characterize the mechanisms underlying the beneficial effects of macrophage PPAR-γ in IBD. Macrophage-specific PPAR-γ deletion significantly exacerbated clinical activity and colonic pathology, impaired the splenic and mesenteric lymph node regulatory T-cell compartment, increased percentages of lamina propria (LP) CD8+ T cells, increased surface expression of CD40, Ly6C, and Toll-like receptor 4 (TLR-4) in LP macrophages, and upregulated expression of colonic IFN-γ, CXCL9, CXCL10, IL-22, IL1RL1, CCR1, suppressor of cytokine signaling 3, and MHC class II in mice with IBD. Moreover, macrophage PPAR-γ was required for accelerating pioglitazone-mediated recovery from dextran sodium sulfate (DSS) colitis, providing a cellular target for the anti-inflammatory effects of PPAR-γ agonists in IBD.


Subject(s)
Colitis/immunology , Inflammatory Bowel Diseases/immunology , Macrophages/metabolism , PPAR gamma/metabolism , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Cells, Cultured , Colitis/chemically induced , Colitis/drug therapy , Colon/pathology , Computational Biology , Dextran Sulfate/administration & dosage , Disease Models, Animal , Gene Expression Regulation/immunology , Humans , Immunomodulation , Inflammatory Bowel Diseases/drug therapy , Macrophages/drug effects , Macrophages/immunology , Macrophages/pathology , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Microarray Analysis , Mucous Membrane/pathology , PPAR gamma/antagonists & inhibitors , PPAR gamma/genetics , PPAR gamma/immunology , Pioglitazone , T-Lymphocyte Subsets/drug effects , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , T-Lymphocyte Subsets/pathology , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , T-Lymphocytes, Regulatory/pathology , Thiazolidinediones/pharmacology , Thiazolidinediones/therapeutic use
3.
J Bacteriol ; 192(12): 3078-92, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20400544

ABSTRACT

Helicobacter pylori is the dominant member of the gastric microbiota and has been associated with an increased risk of gastric cancer and peptic ulcers in adults. H. pylori populations have migrated and diverged with human populations, and health effects vary. Here, we describe the whole genome of the cag-positive strain V225d, cultured from a Venezuelan Piaroa Amerindian subject. To gain insight into the evolution and host adaptation of this bacterium, we undertook comparative H. pylori genomic analyses. A robust multiprotein phylogenetic tree reflects the major human migration out of Africa, across Europe, through Asia, and into the New World, placing Amerindian H. pylori as a particularly close sister group to East Asian H. pylori. In contrast, phylogenetic analysis of the host-interactive genes vacA and cagA shows substantial divergence of Amerindian from Old World forms and indicates new genotypes (e.g., VacA m3) involving these loci. Despite deletions in CagA EPIYA and CRPIA domains, V225d stimulates interleukin-8 secretion and the hummingbird phenotype in AGS cells. However, following a 33-week passage in the mouse stomach, these phenotypes were lost in isolate V225-RE, which had a 15-kb deletion in the cag pathogenicity island that truncated CagA and eliminated some of the type IV secretion system genes. Thus, the unusual V225d cag architecture was fully functional via conserved elements, but the natural deletion of 13 cag pathogenicity island genes and the truncation of CagA impaired the ability to induce inflammation.


Subject(s)
Genetic Variation , Helicobacter Infections/microbiology , Helicobacter pylori/genetics , Helicobacter pylori/metabolism , Inflammation/metabolism , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cell Line , Coculture Techniques , Female , Gene Expression Regulation, Bacterial , Genome, Bacterial , Genomic Islands/genetics , Genomic Islands/physiology , Humans , Mice , Molecular Sequence Data , Phylogeny
4.
Curr Med Chem ; 17(5): 467-78, 2010.
Article in English | MEDLINE | ID: mdl-20015036

ABSTRACT

Since its discovery in the early 1960's, abscisic acid (ABA) has received considerable attention as an important phytohormone, and more recently, as a candidate medicinal in humans. In plants it has been shown to regulate important physiological processes such as response to drought stress, and dormancy. The discovery of ABA synthesis in animal cells has generated interest in the possible parallels between its role in plant and animal systems. The importance of this molecule has prompted the development of several methods for the chemical synthesis of ABA, which differ significantly from the biosynthesis of ABA in plants through the mevalonic acid pathway. ABA recognition in plants has been shown to occur at both the intra- and extracellularly but little is known about the perception of ABA by animal cells. A few ABA molecular targets have been identified in vitro (e.g., calcium signaling, G protein-coupled receptors) in both plant and animal systems. A unique finding in mammalian systems, however, is that the peroxisome proliferator-activated receptor, PPAR gamma, is upregulated by ABA in both in vitro and in vivo studies. Comparison of the human PPAR gamma gene network with Arabidopsis ABA-related genes reveal important orthologs between these groups. Also, ABA can ameliorate the symptoms of type II diabetes, targeting PPAR gamma in a similar manner as the thiazolidinediones class of anti-diabetic drugs. The use of ABA in the treatment of type II diabetes, offers encouragement for further studies concerning the biomedical applications of ABA.


Subject(s)
Abscisic Acid/pharmacology , Hypoglycemic Agents/pharmacology , Abscisic Acid/chemical synthesis , Abscisic Acid/chemistry , Calcium Signaling , Humans , Hypoglycemic Agents/chemical synthesis , Hypoglycemic Agents/chemistry , PPAR gamma/metabolism , Receptors, G-Protein-Coupled/metabolism
5.
Food Chem Toxicol ; 47(6): 1085-92, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19425183

ABSTRACT

In this manuscript, the toxicology and safety of pomegranate seed oil (PSO) was evaluated by in vitro (Ames, chromosomal aberration), and in vivo toxicity tests (acute toxicity and 28-day toxicity in Wistar rats). No mutagenicity of PSO was observed in the absence and presence of metabolic activation up to precipitating concentrations of 5000 microg/plate (Ames test) or 333 microg/ml (chromosome aberration test). The acute oral toxicity study revealed no significant findings at 2000 mg PSO/kg body weight. In the 28-day dietary toxicity study PSO was dosed at concentrations of 0, 10,000, 50,000 and 150,000 ppm, which resulted in a mean intake of 0-0, 825-847, 4269-4330 and 13,710-14,214 mg PSO/kg body weight per day in males-females, respectively. At 150,000 ppm dietary exposure to PSO, a much higher dose than the level of PSO that elicits antidiabetic and anti-inflammatory efficacy, increased hepatic enzyme activities determined in plasma (aspartate, alanine aminotransferase and alkaline phosphatase) and increased liver-to-body weight ratios were observed. However, these effects might be the result of a physiological response to exposure to a very high level of a fatty acid which is not part of the normal diet, and are most likely not toxicologically relevant. The no observable adverse effect level (NOAEL) was 50,000 ppm PSO (=4.3 g PSO/kg body weight/day).


Subject(s)
Lythraceae/toxicity , Plant Oils/toxicity , Animals , Blood Cell Count , Cells, Cultured , Chromosome Aberrations/drug effects , Diet , Escherichia coli/genetics , Female , Humans , Liver Function Tests , Lymphocytes/drug effects , Male , Mutagenicity Tests , Mutagens/toxicity , Organ Size/drug effects , Rats , Rats, Wistar , Salmonella typhimurium/genetics , Seeds/toxicity , Sex Characteristics , Subcellular Fractions/drug effects
6.
Clin Nutr ; 21(6): 451-9, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12468364

ABSTRACT

Conjugated linoleic acid (CLA) is a mixture of positional (e.g. 7,9; 9,11; 10,12; 11,13) and geometric (cis or trans) isomers of octadecadienoic acid. This compound was first shown to prevent mammary carcinogenesis in murine models. Later investigations uncovered a number of additional health benefits, including decreasing atherosclerosis and inflammation while enhancing immune function. The mechanisms of action underlying these biological properties are not clearly understood. The aim of this review is to highlight recent advances in CLA research related to experimental inflammatory bowel disease. In addition, two possible mechanisms of action (i.e. endoplasmic and nuclear) were discussed in detail in the context of enteric inflammatory disorders. Conjugated linoleic acid was first implicated in down-regulating the generation of inducible eicosanoids (i.e. PGE(2) and LTB(4)) involved in early micro-inflammatory events (endoplasmic). More recently, CLA has been shown to modulate the expression of genes regulated by peroxisome proliferator-activated receptors (PPARs; nuclear). In pigs, prolonged dietary CLA treatment stimulated the expression of PPAR-gamma in the muscle. Thus, evidence supporting both mechanistic theories of CLA acting through eicosanoid synthesis and PPAR activity is available. The further understanding of the anti-inflammatory mechanisms of action of CLA may yield novel nutritional therapies for enteric inflammation.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Inflammatory Bowel Diseases/prevention & control , Linoleic Acid/therapeutic use , Animals , Arachidonic Acid/biosynthesis , Disease Models, Animal , Eicosanoids/biosynthesis , Gene Expression Regulation , Humans , Inflammatory Bowel Diseases/diet therapy , Isomerism , Linoleic Acid/physiology , Mice , Receptors, Cytoplasmic and Nuclear/physiology , Swine , Transcription Factors/physiology
7.
Vaccine ; 20(9-10): 1435-44, 2002 Jan 31.
Article in English | MEDLINE | ID: mdl-11818164

ABSTRACT

Porcine CD8(+) lymphocytes are critical for the development of cellular immune responses to bacterial (i.e. CD8alphaalpha(+)) and viral (i.e. CD8alphabeta(+) lymphocytes) pathogens. Vaccination and challenge modulate the kinetics of appearance of CD8(+) cells in peripheral blood. In addition to antigen-mediated modulation, nutritional modulation can also influence cell-mediated immunity. We had previously observed that diets supplemented with a mixture of conjugated linoleic acid (CLA) isomers expanded porcine CD8(+) peripheral blood mononuclear cells (PBMC). The present study aimed to investigate the influence of prior consumption of a nutraceutical, (i.e. dietary CLA) on phenotypes and effector functions of porcine PBMC following immunization with a bacterin or a modified-live viral vaccine. It was demonstrated that the effects of dietary CLA on immune cell phenotype (i.e. numbers of CD8alphabeta(+) cells) persisted after the compound was withdrawn from the diet (i.e. 67 days), whereas effector functions (i.e. antigen-stimulated proliferation and cytotoxicity) disappeared earlier (i.e. 25 days). Specifically, numbers of CD8alphabeta(+) PBMC in pigs that had been fed diets supplemented with CLA were greater than in pigs fed control (i.e. isoenergetic and unsupplemented) diets, regardless of the vaccination treatment. Furthermore, prior dietary CLA supplementation interacted with viral immunization (i.e. modified-live pseudorabies virus (PRV) vaccine) by enhancing both pseudorabies-specific proliferative responses of CD8alphabeta(+) PBMC and granzyme activities of PBMC.


Subject(s)
Antigens, Bacterial/immunology , Antigens, Viral/immunology , CD8-Positive T-Lymphocytes/immunology , Linoleic Acids/administration & dosage , Animals , Apoptosis , Dietary Supplements , Granzymes , Immunophenotyping , Lymphocyte Activation , Nutritional Physiological Phenomena , Receptors, Antigen, T-Cell, alpha-beta/analysis , Serine Endopeptidases/metabolism , Swine
8.
J Nutr ; 131(9): 2370-7, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11533281

ABSTRACT

In vivo vaccination and challenge studies have demonstrated that CD8(+) lymphocytes are essential for the development of cell-mediated protection against intracellular pathogens and neoplastic cells. Depletion of peripheral blood CD8(+) cells interferes with clearance of viruses and intracellular fungi, induction of delayed type hypersensitivity responses and antitumoral activity. In contrast to humans or mice, porcine peripheral CD8(+) lymphocytes are characterized by a heterogeneous expression pattern (i.e., CD8alphabeta and CD8alphaalpha) that facilitates the study of distinctive traits among minor CD8(+) cell subsets. A factorial (2 x 2) arrangement within a split-plot design, with 16 blocks of two littermate pigs as the experimental units for immunization treatment (i.e., unvaccinated or vaccinated with a proteinase-digested Brachyspira hyodysenteriae bacterin) and pig within block as the experimental unit for dietary treatment (soybean oil or conjugated linoleic acid) were used to investigate the phenotypic and functional regulation of CD8(+) cells by dietary conjugated linoleic acid (CLA). Dietary CLA supplementation induced in vivo expansion of porcine CD8(+) cells involving T-cell receptor (TCR)gammadeltaCD8alphaalpha T lymphocytes, CD3(-)CD16(+)CD8alphaalpha (a porcine natural killer cell subset), TCRalphabetaCD8alphabeta T lymphocytes and enhanced specific CD8(+)-mediated effector functions (e.g., granzyme activity). Expansion of peripheral blood TCRalphabetaCD8alphabeta cells was positively correlated (r = 0.89, P < 0.01) with increased percentages of CD8alphabeta(+) thymocytes. Functionally, CLA enhanced the cytotoxic potential of peripheral blood lymphocytes and proliferation of TCRgammadeltaCD8alphaalpha cells. Collectively, these results indicate that dietary CLA enhances cellular immunity by modulating phenotype and effector functions of CD8(+) cells involved in both adaptive and innate immunity.


Subject(s)
CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/physiology , Diet , Linoleic Acid/administration & dosage , Swine/physiology , Animals , Bacterial Vaccines/immunology , CD4-Positive T-Lymphocytes/physiology , CD8-Positive T-Lymphocytes/cytology , Cell Division/drug effects , Killer Cells, Natural/cytology , Linoleic Acid/pharmacology , Lymphocyte Subsets/cytology , Monocytes/enzymology , Phenotype , Receptors, Antigen, T-Cell, alpha-beta/metabolism , Receptors, Antigen, T-Cell, gamma-delta/metabolism , Serine Endopeptidases/blood , Spirochaetales/metabolism , Spirochaetales Infections/prevention & control , T-Lymphocytes, Regulatory/drug effects , Thymus Gland/cytology , Vaccination
9.
J Anim Sci ; 79(3): 714-21, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11263832

ABSTRACT

Early-weaned pigs (n = 64) averaging 5.3 +/- 0.3 kg and distributed into two environments (dirty and clean) were used to evaluate effects of conjugated linoleic acid (CLA) on growth performance, immune competence, and empty body composition. A factorial (2 x 4) arrangement within a split-plot design, with four littermate pigs as the experimental unit for the environment, pig within litter as the experimental unit for dietary treatment, and d-0 body weight used as covariate, were used in data analysis. Diets were formulated to contain CLA at 0, 0.67, 1.33, or 2% and to exceed the NRC (1988) nutrient needs of pigs. Animals were given ad libitum access to feed for 7 wk in three phases (I, 1 to 2; II, 3 to 5; and III, 6 to 7 wk). Within phases, diets were isocaloric and isonitrogenous. In Phase I, as dietary CLA concentration increased, ADG and ADFI decreased linearly (P < 0.05 and P < 0.02, respectively). In Phase II, upon adaptation to dietary CLA supplementation, ADG increased quadratically (603, 623, 622, and 548 g/d; P < 0.01), ADFI decreased linearly (873, 840, 867, and 717 g/d; P < 0.02) and gain:feed ratio tended to increase linearly (691, 742, 715, and 763; P < 0.07). In Phase III, no differences in growth performance were attributed to either dietary or environmental treatments. The poor health status associated with the dirty environment induced a growth suppression; pigs in the clean room had a greater cumulative ADG (P < 0.01) and ADFI (P < 0.01) than pigs in the dirty room. In Phase I, lower plasma urea nitrogen levels observed in pigs found in the dirty room (P < 0.03) indicated a lower protein intake caused by a lower ADFI. The effects of dietary CLA on peripheral phenotypic profiles of lymphoytes did not appear until d 42. However, as indicated by the growth suppression of pigs in the dirty room, the negative effects of the environmental challenge on pig health and growth had already appeared during phase I. On d 42, CLA induced a linear increase in percentages of CD8+ lymphocytes (21.7, 22.3, 28.0, and 32.7%; P < 0.001). These data suggest that a 42-d dietary CLA supplementation preceding a disease challenge could have prevented disease-associated growth suppression. Also, CLA-mediated amelioration of particular infectious diseases will depend on which CD8+ T cell subset (i.e., CD8alphaalpha-immunoregulatory or CD8alphabeta-cytotoxic) is most influenced by dietary CLA supplementation.


Subject(s)
Body Composition , Dietary Fats/pharmacology , Housing, Animal , Linoleic Acid/pharmacology , Lymphocytes/physiology , Swine/growth & development , Swine/immunology , Animal Feed , Animals , Animals, Suckling/growth & development , Blood Urea Nitrogen , Housing, Animal/standards , Leukocyte Count , Lymphocytes/immunology , Phenotype , Weaning
10.
Immunology ; 101(3): 333-41, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11106936

ABSTRACT

A vaccine inducing protective immunity to a spirochaete-induced colitis of pigs predominantly stimulates expansion of CD8+ cells in vivo and in antigen-stimulated lymphocyte cultures. CD8+ cells, however, are rarely considered necessary for protection against extracellular bacterial pathogens. In the present study, pigs recovering from colitis resulting from experimental infection with Brachyspira (Serpulina) hyodysenteriae had increased percentages of peripheral blood CD4- CD8+ (alphaalpha-expressing) cells compared with non-infected pigs. CD8alphaalpha+ cells proliferated in antigen-stimulated cultures of peripheral blood mononuclear cells from B. hyodysenteriae-vaccinated pigs. Proliferating CD8alphaalpha+ cells consisted of CD4-, CD4+ and gammadelta T-cell receptor-positive cells. CD4- CD8alphabeta+ cells from vaccinated or infected pigs did not proliferate upon in vitro antigen stimulation. Of the CD8alphaalpha cells that had proliferated, flow cytometric analysis indicated that the majority of the CD4+ CD8+ cells were large (i.e. lymphoblasts) whereas the CD4- CD8+ cells were predominantly small. Addition of monoclonal antibodies (mAb) specific for either porcine major histocompatibility complex (MHC) class I or class II antigens diminished B. hyodysenteriae-specific proliferative responses whereas addition of mAb to porcine MHC II, but not porcine MHC I, reduced the CD8alphaalpha response. In vitro depletion of CD4+ cells by flow cytometric cell sorting diminished, but did not completely abrogate, the proliferative response of cells from vaccinated pigs to B. hyodysenteriae antigen stimulation. These results suggest that CD8alphaalpha cells are involved in recovery and possibly protection from a spirochaete-induced colitis of pigs; yet, this response appears to be partially dependent upon CD4+ cells.


Subject(s)
Brachyspira hyodysenteriae , CD8-Positive T-Lymphocytes/immunology , Spirochaetales Infections/veterinary , Swine Diseases/immunology , T-Lymphocyte Subsets/immunology , Animals , Antibodies, Monoclonal/immunology , Antigens, Bacterial/immunology , Bacterial Vaccines/immunology , Brachyspira hyodysenteriae/immunology , CD4-Positive T-Lymphocytes/immunology , Cell Division/immunology , Histocompatibility Antigens Class II/immunology , Receptors, Antigen, T-Cell, gamma-delta/blood , Spirochaetales Infections/immunology , Swine , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL
...